These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12756373)

  • 1. Exhaled nitric oxide: a useful aide in pediatric asthma management?
    Lierl MB
    J Pediatr; 2003 May; 142(5):461-2. PubMed ID: 12756373
    [No Abstract]   [Full Text] [Related]  

  • 2. Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma.
    Covar RA; Szefler SJ; Martin RJ; Sundstrom DA; Silkoff PE; Murphy J; Young DA; Spahn JD
    J Pediatr; 2003 May; 142(5):469-75. PubMed ID: 12756375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of montelukast on bronchial provocation tests and exhaled nitric oxide levels in asthmatic patients.
    Berkman N; Avital A; Bardach E; Springer C; Breuer R; Godfrey S
    Isr Med Assoc J; 2003 Nov; 5(11):778-81. PubMed ID: 14650101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of fractional exhaled nitric oxide (F(E)NO) measurements in diagnosing asthma.
    Woo SI; Lee JH; Kim H; Kang JW; Sun YH; Hahn YS
    Respir Med; 2012 Aug; 106(8):1103-9. PubMed ID: 22534041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of methacholine challenges in a multicenter pediatric asthma study.
    Covar RA; Colvin R; Shapiro G; Strunk R
    J Allergy Clin Immunol; 2006 Mar; 117(3):709-11. PubMed ID: 16522478
    [No Abstract]   [Full Text] [Related]  

  • 6. Utility of exhaled nitric oxide in the diagnosis and management of asthma.
    Majid H; Kao C
    Curr Opin Pulm Med; 2010 Jan; 16(1):42-7. PubMed ID: 19797954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of methacholine challenge on alveolar nitric oxide.
    Williamson PA; Clearie K; Vaidyanathan S; Lipworth B
    Thorax; 2009 Jun; 64(6):549-50. PubMed ID: 19478127
    [No Abstract]   [Full Text] [Related]  

  • 8. Variable FEV1 following methacholine inhalation.
    Haynes JM
    Respir Care; 2002 Aug; 47(8):915-7. PubMed ID: 12162803
    [No Abstract]   [Full Text] [Related]  

  • 9. [Asthma therapy in the doctor's office].
    Barczok M
    MMW Fortschr Med; 2010 Feb; 152(7):45-6. PubMed ID: 20364510
    [No Abstract]   [Full Text] [Related]  

  • 10. Factor analysis in the Genetics of Asthma International Network family study identifies five major quantitative asthma phenotypes.
    Pillai SG; Tang Y; van den Oord E; Klotsman M; Barnes K; Carlsen K; Gerritsen J; Lenney W; Silverman M; Sly P; Sundy J; Tsanakas J; von Berg A; Whyte M; Ortega HG; Anderson WH; Helms PJ
    Clin Exp Allergy; 2008 Mar; 38(3):421-9. PubMed ID: 18177490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control maintenance can be predicted by exhaled NO monitoring in asthmatic patients.
    Ozier A; Girodet PO; Bara I; Tunon de Lara JM; Marthan R; Berger P
    Respir Med; 2011 Jul; 105(7):989-96. PubMed ID: 21292461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exhaled nitric oxide in the diagnosis of asthma: comparison with bronchial provocation tests.
    Berkman N; Avital A; Breuer R; Bardach E; Springer C; Godfrey S
    Thorax; 2005 May; 60(5):383-8. PubMed ID: 15860713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exhaled nitric oxide for monitoring childhood asthma inflammation compared to sputum analysis, serum interleukins and pulmonary function.
    Paro-Heitor ML; Bussamra MH; Saraiva-Romanholo BM; Martins MA; Okay TS; Rodrigues JC
    Pediatr Pulmonol; 2008 Feb; 43(2):134-41. PubMed ID: 18085692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conflicting methacholine challenge tests.
    Haynes JM
    Respir Care; 2006 Jan; 51(1):62-6. PubMed ID: 16381620
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma.
    Montuschi P; Mondino C; Koch P; Barnes PJ; Ciabattoni G
    J Allergy Clin Immunol; 2006 Aug; 118(2):347-53. PubMed ID: 16890757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome measures in childhood asthma.
    Skoner DP
    Pediatrics; 2002 Feb; 109(2 Suppl):393-8. PubMed ID: 11826255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of montelukast on subjective and objective outcome measures in preschool asthmatic children.
    Moeller A; Lehmann A; Knauer N; Albisetti M; Rochat M; Johannes W
    Pediatr Pulmonol; 2008 Feb; 43(2):179-86. PubMed ID: 18085698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of budesonide and montelukast in asthmatic children exposed to relevant allergens.
    Peroni D; Bodini A; Miraglia Del Giudice M; Loiacono A; Baraldi E; Boner AL; Piacentini G
    Allergy; 2005 Feb; 60(2):206-10. PubMed ID: 15647042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma.
    Fritscher LG; Rodrigues MT; Zamel N; Chapman KR
    Respir Med; 2009 Feb; 103(2):296-300. PubMed ID: 18805684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of within-subject responses to fluticasone and montelukast in childhood asthma.
    Szefler SJ; Phillips BR; Martinez FD; Chinchilli VM; Lemanske RF; Strunk RC; Zeiger RS; Larsen G; Spahn JD; Bacharier LB; Bloomberg GR; Guilbert TW; Heldt G; Morgan WJ; Moss MH; Sorkness CA; Taussig LM
    J Allergy Clin Immunol; 2005 Feb; 115(2):233-42. PubMed ID: 15696076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.